e8vk
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 25, 2003

ATRIX LABORATORIES, INC.

(Exact name of Registrant as specified in its charter)
         
Delaware   0-18231   84-1043826

 
 
(State or other jurisdiction
of incorporation)
  (Commission
file number)
  (I.R.S. employer
identification no.)
         
2579 Midpoint Drive, Fort Collins, Colorado     80525  

   
 
(Address of principal executive offices)     (Zip Code)

Registrant’s telephone number, including area code: (970) 482-5868



 


TABLE OF CONTENTS

Item 9. Regulation FD Disclosure (Item 12. Results of Operations and Financial Condition).
SIGNATURES
EXHIBIT INDEX
EX-99.1 Press Release


Table of Contents

Item 9. Regulation FD Disclosure (Item 12. Results of Operations and Financial Condition).

     The following information is furnished pursuant to Item 12. “Results of Operations and Financial Condition” and is furnished under Item 9. “Regulation FD Disclosure” in accordance with SEC Release No. 33-8216.

     On April 25, 2003, Atrix Laboratories, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2003. A copy of the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
      ATRIX LABORATORIES, INC.
 
 
    By:   /s/ Brian G. Richmond

Brian G. Richmond
Chief Financial Officer, Secretary and Treasurer

Date: April 25, 2003

 


Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Description

 
99.1   Press Release dated April 25, 2003